Search Results
Viewing: 81-90 of 288 | All
News
Nationwide Children’s Hospital Announces Plans to Dedicate the Abigail Wexner Research Institute
Ms. Wexner’s partnership with her fellow board members, Chief Executive Officer Steve Allen, MD, and the Nationwide Children’s executive team made this evolution possible. In recognition of Dr. Allen’s role, Nationwide Children’s will also establish the Allen Distinguished Scholar in Pediatric Research.
News
Nelson Weichold Named Chief Financial Officer at Nationwide Children’s
Nelson Weichold, MHA, has been named chief financial officer at Nationwide Children’s Hospital, effective June 5.
Article
Featured Physician
Sean Tabaie, MD, MBA, FAAOS, FAOA, is a pediatric orthopedic surgeon at Nationwide Children’s Hospital and clinical professor at The Ohio State University College of Medicine. At Nationwide Children’s, Dr. Tabaie serves as the director of the Cerebral Palsy & Neuro-Orthopedics Program, medical director of the Honda Center for Gait Analysis and Mobility Enhancement, director of the Neuro-Orthopedics Fellowship, associate director of the Pediatric Orthopedics Fellowship and associate director of the Orthopedic Innovation Program.
Specialty
Center for Comprehensive Spine Care
The Spine Program at Nationwide Children's focuses on managing congenital, developmental and neuromuscular-related spine conditions. Our approach provides a long-term treatment plan of surgical or non-surgical interventions that will allow for optimal skeletal growth.
News
Nationwide Childrens Hospital and OhioHealth partner to bring emergency services for children and adults to Lewis Center
OhioHealth Contact: Mark Hopkins, Director, Media Relations mark.hopkins@ohiohealth.com (o) 614.544.4248 (c) 614.309.8674 Nationwide Children’s Hospital Contact: MediaRelations@nationwidechildrens.org (o) 614.355.0495 (c) 614.519.5130 Beginning at 8 a.m.
News
From Bench to Bedside: Patient with Duchenne Muscular Dystrophy Receives First Dose of Gene Therapy Developed at Nationwide Children’s Hospital
In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children’s, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children’s Hospital, where the therapy was invented and initially tested.
News
Nationwide Children’s Hospital Becomes Certified Site for Gene Therapy for Transfusion-Dependent Beta Thalassemia
Nationwide Children’s Hospital has been designated a qualified treatment center for Zynteglo® (betibeglogene autotemcel), a a gene therapy approved for the treatment of people with beta thalassemia who require regular red blood cell transfusions.
News
Cardinal Health Donates $1 Million to Nationwide Childrens Hospital Supporting the Work of its Tissue Engineering Program
Cardinal Health recently donated $1 million to Nationwide Children’s Hospital to help advance the work and research of its Tissue Engineering Program.
News
Nationwide Children’s Hospital Tops Forbes List of ‘America’s Best Employers for Women’
Nationwide Children’s Hospital has ranked first on Forbes’ 2024 “America’s Best Employers for Women” list.
News
1 Year In, the CCDI Molecular Characterization Initiative Has Analyzed Samples From Over 1,000 Patients
The CCDI Molecular Characterization Initiative (MCI) is a project that aims to collect, analyze and report clinical and molecular data and is currently supporting Children’s Oncology Group (COG)-affiliated clinicians in choosing the best treatment for each child through precision diagnosis. This program is part of the National Cancer Institute (NCI) Childhood Cancer Data Initiative (CCDI), a national commitment and community-wide effort to harness data in ways that speed up progress in childhood cancer. Announced last year, the MCI is a collaboration among NCI, part of the National Institutes of Health, COG and Nationwide Children’s Hospital and is the largest initiative of its kind in the United States.